High-dose idarubicin, cyclophosphamide and melphalan as conditioning for autologous stem cell transplantation increases treatment-related mortality in patients with multiple myeloma: results of a randomised study-Reference-Cited by-同舟云学术

High-dose idarubicin, cyclophosphamide and melphalan as conditioning for autologous stem cell transplantation increases treatment-related mortality in patients with multiple myeloma: results of a randomised study

Published:2005-08 Issue:4 Volume:130 Page:588-594
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Fenk R.,Schneider P.,Kropff M.,Huenerlituerkoglu A. N.,Steidl U.,Aul C.,Hildebrandt B.,Haas R.,Heyll A.,Kobbe G.,

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2005.05641.x/fullpdf

Reference18 articles.

1. Intensification of the stem cell transplant induction regimen results in increased treatment-related mortality without improved outcome in multiple myeloma

2. Impact of complete remission with intensive therapy in patients with responsive multiple myeloma

3. A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

4. Transplantation for multiple myeloma: who, when, how often?

5. High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting the role of alkylating agents in multiple myeloma: Up-to-date evidence and future perspectives;Critical Reviews in Oncology/Hematology;2023-07

2. Survival outcomes following autologous stem cell transplant with melphalan 140mg/m² versus 200mg/m² preparative regimens in patients with multiple myeloma;Leukemia & Lymphoma;2023-05-18

3. High dose (conditioning) regimens used prior to autologous stem cell transplantation in multiple myeloma;Transplantation and Cellular Therapy;2022-09

4. High-Dose Bendamustine, Etoposide, Cytarabine, and Melphalan (BeEAM) Conditioning Before Autologous Transplantation for Patients With Multiple Myeloma;Transplantation and Cellular Therapy;2022-08

5. Adding bendamustine to melphalan before ASCT improves CR rate in myeloma vs. melphalan alone: A randomized phase-2 trial;Bone Marrow Transplantation;2022-04-20